ADHEXPHARMA
LIVE

Serial Number

79238019

Owner

BURGUNDY VENTURES EUROPE

Attorney

Mary Margaret L. O'Donnell

Filing Date

May 9, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ADHEXPHARMA Trademark

Serial Number: 79238019 • Registration: 5969642

ADHEXPHARMA is a trademark filed by BURGUNDY VENTURES EUROPE on May 9, 2018. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

BURGUNDY VENTURES EUROPE (2 trademarks)

11b, boulevard Joseph II
Luxembourg L1840 , LU

Entity Type: 99

Trademark Details

Filing Date

May 9, 2018

Registration Date

January 28, 2020

Published for Opposition

November 12, 2019

Goods & Services

Dressings articles, namely, bandages in liquid form and in the form of gels in the nature of antiseptic liquid bandages and bandages for skin wounds; non-adherent medicated compresses and hydrogels for medical use; dermatological pharmaceutical products and medicinal preparations for wound care; medicated compresses; adhesives for medical use, namely, medical adhesive tape; adhesives for suturing wounds, namely, adhesive bandages; adhesive ribbons and films for pharmaceutical and medical use, namely, adhesive bandages; orodispersible films for pharmaceutical and medical use, namely, drug delivery agents in the form of films that facilitate the delivery of pharmaceutical preparations; oral adhesive films and sublingual films for pharmaceutical or medical use, namely, drug delivery agents in the form of films that facilitate the delivery of pharmaceutical preparations; transdermal patches facilitating the delivery of pharmaceutical active ingredients or pharmaceutical preparations into the skin and into the bloodstream featuring preparations for the treatment of pain and diseases and disorders, namely, of the skeletal, muscular, nervous, endocrine, immune, circulatory, hematological, cardiovascular, cardiopulmonary, lymphatic, respiratory, digestive, genitourinary, urinary, reproductive, psychiatric, metabolic, oncological, hepatological, ophthalmic, neurological, gastrointestinal, hormonal and integumentary systems; medicated creams for treating dermatological conditions; medical diagnostic test media in the form of patches in the nature of strips for measuring blood analysis, urine analysis, saliva analysis, dermatological analysis; adhesives for surgical, dental or medical use, namely, adhesive plasters for medical purposes

Patches and wipes impregnated with cosmetics, namely, patches containing skin lotion and pre-moistened cosmetic wipes; cosmetic creams and masks

Adhesives for use in industry; adhesives for industrial use intended for the manufacture of transdermal patches, surgical bandages, dressings, electrodes, diagnostic devices and medical devices; adhesives for industrial use intended for the manufacture of cosmetic products; chemical preparations and biological compounds in the nature of biological preparations for industrial use intended for the manufacture of adhesives, drugs, pharmaceutical patches, orally disintegrating films, oral adhesive films, sublingual films, diagnostic devices and medical devices; chemical preparations and biological compounds in the nature of biological preparations for industrial use intended for the manufacture of cosmetic patches; chemical and biological compounds, namely, pharmaceutical and cosmetic active ingredients, all for industrial use in the nature of active chemical ingredients intended for the manufacture of pharmaceuticals and cosmetic pills, capsules, powder, lotion, patches, and dressings

Suture materials; surgical sterile sheets; drainage tubes for medical use; pressure orthopedic support bandages; blood collection bags for medical use; electrodes for medical use; diagnostic apparatus for medical use for testing blood sugar levels, body temperature, heart pulsation, breathing capacity, blood pressure, molecular oxygen concentration, DNA, cancer cells; apparatus for the administration of medicinal substances, namely, infusion and injection devices for administering drugs; tubing for medical use for administering medicines; medical apparatus to introduce pharmaceutical preparations into the body; implantable medical devices for the subcutaneous release of medicinal substances, namely, implantable subcutaneous drug delivery devices sold empty; droppers for medical purposes, namely, droppers for administering medication, sold empty

Medical research; design and development of medical technologies, namely, technology research in the field of medical instruments and devices, medical adhesives and patches, medical oral thin films; scientific research and development services; scientific research and development in the medical sector; medical research laboratory services; development of pharmaceutical preparations and medicines; pharmaceutical research services, namely, analytical and industrial research services for the manufacture of pharmaceuticals and medicines

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 28, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jun 26, 2020 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 22, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 6, 2020 FICS
FINAL DISPOSITION PROCESSED
May 6, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 28, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 28, 2020 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 24, 2020 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 8, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 8, 2020 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2019 NPUB
PUBLISHED FOR OPPOSITION
Nov 12, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Nov 8, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 23, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 23, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 23, 2019 NONP
ASSIGNED TO LIE
Oct 10, 2019 ALIE
EXPARTE APPEAL TERMINATED
Oct 9, 2019 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 9, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 9, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 9, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 9, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 9, 2019 CNEA
EX PARTE APPEAL-INSTITUTED
Sep 20, 2019 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Sep 20, 2019 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Sep 20, 2019 EXAF
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2019 CRFA
ASSIGNED TO LIE
Aug 29, 2019 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 23, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 21, 2019 GNFN
FINAL REFUSAL E-MAILED
Mar 21, 2019 GNFR
FINAL REFUSAL WRITTEN
Mar 21, 2019 CNFR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 5, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 5, 2019 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 5, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 5, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 5, 2019 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Nov 29, 2018 NREP
REFUSAL PROCESSED BY IB
Sep 29, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 11, 2018 RFCS
REFUSAL PROCESSED BY MPU
Sep 11, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 4, 2018 RFCR
NON-FINAL ACTION WRITTEN
Sep 3, 2018 CNRT
ASSIGNED TO EXAMINER
Aug 30, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 11, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 7, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 2, 2018 REPR